Introduction
============

Traumatic spinal cord injury (SCI) is a debilitating condition with a reported global incidence ranging from 10 to 80 million per population per year ([@B55]; [@B27]). The changes in the cortex and the thalamus following SCI have been studied extensively ([@B9]; [@B1]; [@B18], [@B19]). Deafferentation caused by SCI has been shown to induce short (days) and long-term (months) alterations in brain architecture and neuronal connections ([@B26]; [@B18]). However, it is still unclear how these changes translate into behavior and recovery.

Evidence from rodent models suggest that within minutes after SCI, decreases in spontaneous neuronal activity are observed in cortical areas that correspond to the injured limbs as well as cortical areas that normally process information from the non-injured limbs ([@B1]). Moreover, these decreases in spontaneous activity are correlated with poor recovery. Thus, an intervention to attenuate and reverse the injury-induced reduction in spontaneous cortical activity has the potential to accelerate post-SCI neurorehabilitation. Indeed, there are ongoing efforts to modulate the activity of the peripheral and central nervous system after SCI with the goal of enhancing recovery. A bulk of evidence demonstrates that peripheral nerve function is affected by SCI ([@B8]; [@B57]) highlighting the importance of regulating peripheral nerve function during critical phases of SCI. For example, an intensive 6 week peripheral nerve stimulation regimen has been shown to prevent long term changes in axonal function post-SCI ([@B33]). Other non-pharmacological and non-invasive approaches such as spinal cord stimulation (functional electrical stimulation) ([@B40]) has been shown to improve recovery outcomes post-SCI. Functional electrical stimulation of central pattern generator mechanisms has been shown to improve responses in patients with complete or incomplete SCI ([@B23]). Recent research has shown that the application of epidural electric stimulation (EES) improves spinal networks post-injury through the restoration of locomotion ([@B12]; [@B16]). The future of neurorehabilitative strategies would involve using non-invasive treatments involving electrical stimulation.

In addition to assessing corticospinal transmission times, non-invasive brain stimulation technologies are additionally being used as therapies for a variety of neurological disorders and diseases ([@B51]; [@B20]). A prominent FDA approved ([@B47]), non-invasive technology shown to produce long lasting increases in cortical excitability is transcranial magnetic stimulation (TMS). TMS has been shown to induce neuronal excitation and plasticity beyond the stimulation period in several injury and disease conditions ([@B34]; [@B53]), including in rodent models of brain injury ([@B39]; [@B52]). Reports in the past have demonstrated that applying TMS years after SCI has improved motor and sensory outcomes ([@B5]; [@B32]). Another study showed that high-frequency repetitive TMS (rTMS) stimulation applied months after SCI improved motor function compared to the same treatment with sham stimulation ([@B6]).

This led us to test whether applying TMS over the cortex to enhance excitation, within days and weeks after the injury was sustained, could facilitate recovery in an animal model.

A contusion model of thoracic injury (T9) in adult rats shown to mimic similar pathological changes to human SCI ([@B43]) was used. We tested if daily TMS sessions starting within minutes or weeks after the injury would accelerate neuroplasticity. MEP was used to test the effectiveness of TMS treatment by evaluating the changes in integrity of motor pathways ([@B13]; [@B45]). Weekly behavioral testing was conducted to assess gross behavior improvement. High-resolution functional MRI was used to detect cortical functional responses evoked by tactile limb stimulation ([@B49], [@B48]; [@B21]; [@B37]; [@B39]) as a means to evaluate recovery of ascending spinal pathways.

Our results support the hypothesis that rescuing the hypoactive neuronal activity by TMS can accelerate post-SCI neuroplasticity.

Materials and Methods {#s1}
=====================

All animal procedures were conducted in accordance with the NIH *Guide for the Care and Use of Laboratory Animals* and approved by the Johns Hopkins University Animal Care and Use Committee.

Animals
-------

17 male adult Sprague-Dawley rats (Harlan Laboratories) were provided with food and water *ad libitum* and housed in pairs (standard housing).

Spinal Cord Injury
------------------

An hour prior to surgery, rats were injected with buprenorphine (Buprenex; 0.05 mg/kg, s.c.). Animals were anesthetized using a Ketamine (75 mg/kg, i.p.) and Dexmedetomidine (0.25 mg/kg, i.p.) cocktail. An infinite horizon impactor was used to induce SCI. Displacement and velocity were tested to ensure instrument reliability ([@B50]). A midline sagittal incision centered over the T9 vertebra was performed, and the muscles and connective tissue were separated to expose the spinal segments. Dorsal laminectomy of the T9 segment was followed. Afterward, adson forceps was used to clamp the spinal column, rostral and caudal to the laminectomy. The animal was transferred to the IH impactor and was centered with the exposed site immediately beneath the impactor. The impactor was lowered with a 4 mm tip above the exposed spinal cord segment. A 200 kdyne injury was used to impact the exposed segment, resulting in a severe contusion SCI ([@B11]; [@B2]).

After the injury the muscle and fascia were sutured with a running 5--0 vicryl absorbable suture and the skin was closed using wound clips. Rats were given 10 ml of Ringers solution (i.p), 0.05 mL of gentamicin (i.m) and buprenorphine (Buprenex; 0.05 mg/kg, s.c.), and put in a 37°C incubator. Once in the incubator, Antisedan (1 mg/kg; i.m.) was administered to reverse the anesthesia. Water Gel pack and food pellets were provided at the bottom of the cage up to 72 h after SCI. Bladder expression was performed twice daily until the animals regained bladder control. Buprenorphine was administered twice a day for 48 h. Administration of 10 mL of Ringer's solution (i.p.) and 0.05 mL of gentamicin (i.m.) continued daily for 7 days. Wound clips were removed 7--10 days after injury. Animals showing lack of movement were not included in this study.

Transcranial Magnetic Stimulation
---------------------------------

For TMS application, rats were anesthetized with 2% isoflurane and their heads secured using a stereotaxic frame. The TMS system (Magstim, Rapid2) was equipped with a figure eight, 25 mm custom rodent coil which was placed over the midline between bregma and lambda, covering both left and right sensorimotor cortices. The stimulus was delivered 3-times a week for 6 weeks using the following settings: 4 s cycles of 10 Hz stimuli, 26 s interval between cycles, and 7 cycles (total of 280 pulses per day, 1680 total stimuli). The length of this stimulation treatment was 10 min. Injured rats were divided into three groups:***Acute-TMS Group (n = 7)***, TMS delivered within 10 min following SCI and wound suturing;***Chronic-TMS Group (n = 5)***, TMS beginning 2 weeks following SCI; ***No-TMS Group (n = 5)***. The TMS coil was placed exactly in the same position as in the experimental groups but no stimulation was applied. At the end of the procedure the animals were placed in a clean cage on a 37°C warming tray and monitored for return to normal activity.

Basso, Beattie, and Bresnahan (BBB) Locomotor Scale
---------------------------------------------------

In order to assess motor function post-SCI, rats were placed in an uninterrupted open field and allowed unrestricted movement. Rats were allowed to move freely and were scored by their ability to use their hindlimbs. A 21- point BBB locomotion scale was used based on the movement of joints, placement of paws and coordination of forepaw and hindlimbs ([@B4]).

Gridwalk Test
-------------

Motor behavior was assessed by performing the weekly gridwalk test. The gridwalk test was used to evaluate sensory motor coordination after SCI. In this test, the rats were examined in a long walkway consisting of irregularly spaced metal rungs over which the animals must travel in order to reach the end. The number of foot fall errors where the hindlimb of a test animal failed to grasp a bar and fell between the bars were recorded.

Electromyography
----------------

Motor evoked potentials (MEP) in response to TMS were recorded with needle electrodes inserted into both forepaws. The corticospinal excitability was measured in response to stimulatory TMS at 100% capacity for 10 single stimuli. Inter-peak latency responses to the first TMS stimulus in each rat forepaw were measured using Spike 2 software (CED, Cambridge, United Kingdom). Inter-peak latency was calculated as the difference in time between the two consecutive peaks of the MEP.

fMRI Acquisition and Data Analysis
----------------------------------

Rats were anesthetized with dexmedetomidine (0.1 mg/kg/h, SC) which is known to preserve neurovascular coupling ([@B36]). Rats were then placed in an ultra-high field 11.7 Tesla/16 cm horizontal bore small-animal scanner (Bruker BioSpin, Rheinstetten, Germany). A 72-mm quadrature volume coil and a 15-mm-diameter surface coil were used to transmit and receive magnetic resonance signals, respectively.

Respiration rate, heart rate, rectal temperature, and partial pressure of oxygen were continuously monitored throughout fMRI measurements (Starr Life Sciences, Pennsylvania, United States). fMRI, gradient echo, echo planar imaging was used with a resolution of 150 × 150 × 1000 μm. Five 1 mm thick coronal slices covering the primary somatosensory cortex (S1) were acquired \[effective echo time (TE), 11 ms; repetition time (TR), 1000 ms; bandwidth, 250 KHz; field of view (FOV), 1.92 × 1.92 cm; and matrix size, 128 × 128\]. A T2-weighted RARE sequence was used to acquire high-resolution anatomical images (TE, 10 ms; TR, 5000 ms; bandwidth, 250 KHz; FOV, 1.92 × 1.92 cm; and matrix size, 256 × 256) corresponding to the fMRI measurements. Two needle electrodes were inserted into the left and right forepaws or hindlimbs to deliver electrical stimulation. Electrical stimulation (9 Hz, 0.3 mA, and 0.3 ms) was applied for two trains of 20 s with 40 s rest in between. Cross-correlation maps were cluster-size thresholded for an effective significance of *P* \< 0.05 using Stimulate (University of Minnesota).

Statistical Analysis
--------------------

Statistical analysis was performed using Graphpad Prism package (San Diego, CA, United States). For the BBB scores, gridwalk, and fMRI studies, we used one-way ANOVA with multiple comparisons (followed by sidak *post hoc* test) to verify differences between groups. Linear regression analysis was also used for gridwalk test. MEP data were analyzed using student's *t*-test. Data are presented as means ± SEM. *P* value of \<0.05 was considered significant for all the data analysis. ^∗^, ^∗∗^, and ^∗∗∗^ correspond to *p* \< 0.05, *p* \< 0.01, and *p* \< 0.001.

Results
=======

BBB Locomotor Scale
-------------------

Initial assessment of SCI motor recovery was done using the BBB scale which has been shown to be informative in evaluating post-SCI function in rats ([@B4]). The score (0--21) represents different combinations of movements and the associated degree of recovery where an increased score represents better functional motor recovery.

We compared the change in the mean score between the TMS-treated groups (acute and chronic) and no-TMS group ([Figure 1](#F1){ref-type="fig"}). The BBB score for the acute-TMS group (*n* = 4) had the best improvement amongst the three groups with a mean initial score of 10.5 ± 3.8 in the first week and continuous improvement leading to a mean score of 19 ± 1.14 in week 9. The chronic TMS group (*n* = 4) and the no-TMS group (*n* = 4) had similar BBB scores with steady improvement throughout the study. By the end of the 9th week all groups reached similar scores. We compared scores over the period of 9 weeks and report that the acute-TMS group had overall significance (*p* = 0.004) with a mean score of 15.53 ± 0.84 vs the chronic-TMS group (12.5 ± 1.41). The mean overall BBB score was also significant (*p* = 0.0015) for acute (15.53 ± 0.84) vs no-TMS group (12 ± 1.39). The comparison between the chronic vs the no-TMS group did not yield any statistical significance. This result showed that early intervention using TMS resulted in a better locomotor recovery following SCI.

![Graph showing effects of TMS treatment on SCI rats assessed by BBB scores over 9 weeks. BBB scores were assessed on a 21-point score (21 being a normal motor function). The scores show that the acute-TMS group (*n* = 4) showed significant improvement in scores over chronic (*p* = 0.004, *n* = 4) and no-TMS (*p* = 0.0015, *n* = 3) groups. The chronic-TMS group did not show significant improvement over the no-TMS group. Statistical analysis was performed with one-way ANOVA involving multiple comparisons.](fnins-13-00387-g001){#F1}

Gridwalk Test
-------------

Data in ([Figure 2A](#F2){ref-type="fig"}) show the percent footfall errors for each individual animal from all three groups over a period of 9 weeks. The acute-TMS group had the lowest percent footfall errors compared to the chronic and no-TMS groups. Many recovery processes show a rapid initial recovery phase followed by gradual slowing and approach a stable long-term level (asymptote), although this asymptote may not be reached during the short time of the experiment. Such processes are often fitted by an exponential decay curve. We fitted an exponential curve (data figure not shown) to the mean missed steps data from each group and tested whether the asymptotes differed between groups. Exponential curve fit equation is (*y* = a + be-t/τ, where "a" is the asymptotic recovery value, and τ is the recovery time constant in weeks and a + b = 100%). The estimates for the asymptotes (long-term values) for the three groups are 1. Acute-TMS 7.0 +/- 2.8; 2. No-TMS 34.9 +/- 5.8; 3. Chronic-TMS 26.4 +/- 3.3. The *p*-values for the differences between groups are: *P* \< 0.005 when comparing 1 vs 3 (*t* = 4.48 on 6 df) and when comparing 1 vs 2 (*t* = 4.35 on 6 df).

![**(A)** Line graph showing mean gridwalk scores measured in terms of percent footfall errors across a period of 9 weeks for each animal across all groups. The acute-TMS group had the lowest percent footfall errors compared to the chronic and no-TMS group. **(B)** One-way ANOVA with multiple comparison analyses show significant improvement in percentage of footfall errors measured in acute (*n* = 4) vs chronic (*n* = 4, *p* = 0.0009) and acute vs no-TMS groups (*n* = 3, *p* = 0.0015). No significant differences were found between the chronic vs no-TMS groups across 9 weeks.](fnins-13-00387-g002){#F2}

In addition, we compared the percent of foot fall errors between the groups ([Figure 2B](#F2){ref-type="fig"}) using multiple-comparison ANOVA analysis. Consistent with BBB score analysis, the acute-TMS rats had the lowest footfall error rate through 9 weeks with mean percent error rate of 37.75 ± 11.38 ([Figure 2B](#F2){ref-type="fig"}) during the first week which consistently improved to 20.21 ± 6.3 in week 5 and 11.77 ± 2.9 at week 9. The acute-TMS group showed a significantly lowered foot fall error rate compared to chronic TMS (*p* = 0.0009) and no-TMS group (*p* = 0.0015). We report that the chronic- TMS group did not show significant differences in the footfall error rate compared to the no-TMS group.

MEP Assessment
--------------

The MEP test is commonly used as a read-out of corticospinal excitability to probe the physiology of the motor cortex. Measuring MEPs provide quantification of this corticospinal excitability^,^ which TMS is known to modulate ([@B7]). Our goal was to investigate whether TMS can improve motor activity in the limbs following SCI. This was assessed through changes in the late-latency MEPs in the limbs. Inter-peak latency to evaluate the motor pathway integrity was calculated as the difference in time between the two consecutive peaks of the MEP ([Figure 3A](#F3){ref-type="fig"}). For statistical analysis, late latency parameters were compared between acute, chronic and non-TMS treatment groups using a Student's *t*-test. The inter-peak latencies for MEP calculated for both the right and left forelimbs were grouped together. Data graph ([Figure 3B](#F3){ref-type="fig"}) show that the acute-TMS receiving rats have significantly longer inter-peak latencies (Mean ± SEM, 0.002908 ± 0.0009249, and *n* = 4) compared to no-TMS group (Mean ± SEM, 0.0009024 ± 0.000142, and *n* = 7). Though the chronic-TMS group had a longer inter-peak latency than the no-TMS group it did not show a significant difference.

![MEP responses recorded from the forepaws evoked by transcranial magnetic stimulation (TMS) pulses. **(A)** Representative MEP trace showing the distance in time between consecutive maximal peaks defined as inter-peak latency. **(B)** Data summary show a significant increase in inter-peak latency in rats treated with acute-TMS vs the no-TMS group (*p* = 0.018, denoted by ^∗^). The chronic vs. no-TMS group did not show significant differences in inter-peak latencies.](fnins-13-00387-g003){#F3}

TMS Treatment Enhances the Evoked fMRI Signal
---------------------------------------------

High resolution fMRI was used to measure somatosensory responses in SCI animals after TMS treatment. Evoked blood-oxygenation-level-dependent (BOLD) fMRI in the primary somatosensory cortex was measured in response to contralateral hind limb and forepaw stimulation 10 weeks post-SCI.

Our results demonstrate that the acute-TMS group (*n* = 7) showed the greatest increase in sensory responses evoked by stimulation of right hindlimb (RHL) with 56.29 ± 7.61 activated pixels, and left hindlimb (LHL) with 52.29 ± 6.73 activated pixels ([Figure 4A](#F4){ref-type="fig"}). The chronic-TMS group had an intermediate response in both limbs and the sham control group failed to evoke any cortical response. Data analysis ([Figure 4C](#F4){ref-type="fig"}) of sensory responses showed significantly larger response in terms of activated pixels in the acute-TMS group: 56.29 ± 7.61 (RHL) and 52.29 ± 6.73 (LHL). The chronic-TMS showed 49.4 ± 10.45 (RHL) and 38.6 ± 2.69 (LHL) activated pixels exhibiting moderate response. The no-TMS group showed very few activated pixels in response to stimulation: 26.8 ± 2.41 (RHL) and 28.4 ± 4.02 (LHL). One way ANOVA revealed significant differences in the means between the groups (*F*(5,28) = 3.554, *p* = 0.01). We also used *t*-test to report that the acute-TMS group was significantly larger than the no-TMS group (*p* = 0.0043). The chronic group also show an improved response over the no-TMS group (*p* = 0.02).

![**(A)** fMRI measurements: were obtained 10 weeks after SCI. Individual fMRI cross-correlation statistical maps demonstrate increases in fMRI responses (in red) to contralateral stimulation of hindlimbs in the acute-TMS (*n* = 7) and chronic-TMS (*n* = 5) treatment groups, but not in the no- TMS group (*n* = 5). **(B)** Show sensory responses to stimulation of forepaws. **(C)** Data plots shows that the acute-TMS group demonstrated the greatest sensory responses to right and left hindlimb (LHL) stimulation compared to chronic-TMS and no-TMS groups. Statistical significance was determined by one-way ANOVA \[*F*(5,28) = 3.554, *p* = 0.01)\].](fnins-13-00387-g004){#F4}

We also measured somatosensory responses to forepaw stimulation ([Figure 4B](#F4){ref-type="fig"}), as the T9 contusion should not have affected evoked forepaw response. Indeed, the extent of the fMRI responses to left and right forepaw stimulating was similar to values that were reported previously ([@B35], [@B36],[@B37]; [@B21]). The fMRI results showed that injured rats receiving TMS therapy immediately after the injury demonstrated the most extensive cortical activity in the weeks following injury.

Discussion
==========

Non-invasive Brain Stimulation Improves Outlook in SCI
------------------------------------------------------

The aim of this study was to test whether applying TMS over the brain in minutes and weeks following SCI could facilitate recovery. In this study, rats subjected to SCI were assessed by behavior and physiological methods. Behavioral testing was evaluated by BBB score and gridwalk testing, and changes in corticospinal excitability was measured by MEP testing. Changes in cortical sensory information were evaluated using BOLD fMRI. TMS has been shown to be effective in facilitating recovery, enhancing neuroplasticity and alleviating pain in a number of neurological disorders and injuries ([@B39]; [@B52]) In addition, TMS has been shown to restore the transmission of corticospinal information and improve outcome in patients with SCI ([@B5]; [@B31]).

There is a plethora of pharmacological and exercise therapy approaches in promoting brain plasticity after SCI. The use of 5-HT pharmacotherapy has been shown to promote cortical plasticity after SCI, especially in the improvement of behavioral outcome ([@B17]). Exercise interventions have also been shown to promote brain plasticity thereby aiding in the motor recovery in both the spinal cord and the brain. Animal studies involving exercise interventions have been shown to promote plasticity through the upregulation of various neurotrophic factors in the spinal cord ([@B38]; [@B28]). In an animal model of traumatic brain injury we have recently demonstrated that combining enriched environment with TMS augment rehabilitation ([@B52]). Therefore, it is manifesting that a combination of therapies that target different physiological and neuroplasticity mechanisms might also be useful in facilitating recovery after SCI. A non-invasive method that changes cortical excitability thereby inducing plastic changes appears promising in the SCI arena ([@B20]).

Immediate Intervention Improves Recovery
----------------------------------------

One of the goals of this study was to determine the timeframe for effective intervention. It has been shown in rats that cortical reorganization after SCI occur in several temporal stages. Long term cortical expansion assessed by fMRI 1 to 3 months after injury ([@B15]) is preceded by early changes in reorganization that occur within a week after injury ([@B56]). Early expansion of cortical representations has been shown to be associated with decreases in spine density in the deafferented cortical areas in rats ([@B29]). It has also been shown that a complete thoracic SCI in anesthetized rats immediately changes state of cortical activity ([@B59]). In addition, changes in cortical representation after SCI occur within hours using electrophysiological techniques ([@B25]). This highlights the use of an early intervention strategy to mediate changes in cortical function that might benefit functional outcome.

An important factor to be taken into consideration for the intervention is the time elapsed after injury. The optimal window of time for initiating therapy, to promote recovery following SCI may be varied. Although studies using TMS were performed in the chronic phase of SCI ([@B31], [@B30]), this is the first report to evaluate the long-term effects of an acute-TMS application.

We report that changes in sensory perception are accompanied by increases in the motor outputs induced by acute TMS therapy. This is similar to previous research results that report that electrochemical neuromodulation restores motor activity in rodents with spinal cord contusion injury ([@B3]). We also report that the beneficial effects of TMS in the acute group were seen earlier in the behavioral studies with all groups eventually catching up. Rapid improvement in the rehabilitation process is very impactful for human subjects, as this will reduce length of hospitalization, total cost of care, and minimize potential complications from a prolonged recovery process.

Multimodal Methods to Quantify Behavioral, Motor and Sensory Outcomes
---------------------------------------------------------------------

There are several behavioral tests in animal model that have been shown to be useful to monitor and evaluate functional outcome after SCI. These include the BBB scale, gridwalk test ([@B44]; [@B14]) plantar test ([@B22]), and tail flick test. Although these tests are used frequently, they are highly variable and often do not have the sensitivity to monitor subtle and long-term changes. For example, the gridwalk test was shown to have a high degree of variability, due to the number of footfall errors correlating poorly with the BBB scoring system in rats ([@B42]). In our study, the gridwalk and BBB scoring correlated well in terms of locomotor recovery. The BBB locomotion assessment of rat's post-SCI, showed that the acute-TMS group recovered the fastest, with recovery plateauing by week 5. Additionally the acute-TMS group had a significantly better BBB score than the chronic and no-TMS group This is in agreement with previous evidence that show gradual recovery by week 5 ([@B46]; [@B54]). Gridwalk test results indicated that the acute-TMS group had the best scores with the fewest footfall errors compared to the chronic and no-TMS groups. We observed a trend of increased performance in BBB scoring and gridwalk test in the chronic-TMS group compared to no-TMS group although this trend did not reach significance. This suggests that TMS therapy could benefit if it starts at chronic stage after SCI injury (2 weeks post-SCI), but will be more effective if it begins in acute stages after the injury.

Previous studies have used MEP as a quantification method to assess recovery after SCI ([@B13]). In our study, the MEP test was performed to assess the extent of locomotor recovery post-TMS therapy. However, our results show that applying TMS to the sensorimotor cortex after SCI resulted in significantly longer inter-peak latency of MEPs. This may suggest a reorganization of motor pathways ([@B10]). As TMS is known to facilitate neuroplasticity, it is feasible that the applied TMS is facilitating reorganization of this corticospinal pathway as an adaptation to the global cortical silencing that occurs following SCI ([@B1]).

Various imaging techniques have been used successfully to monitor SCI changes. fMRI has been shown to be a useful tool in detecting changes in brain pathology after SCI ([@B58]) and brain connectivity, before and after SCI in mice ([@B41]). Furthermore, fMRI has been used to observe increased response to forepaw stimuli in the primary somatosensory region after thoracic SCI ([@B24]). Here we used high-resolution fMRI obtained at ultra-high field of 11.7 T to monitor if TMS therapy induces post-injury neuroplasticity. We determined the optimal TMS therapy timing that lead to the greatest fMRI responses to limb stimulation. fMRI results from our study showed greater somatosensory response in the acute-TMS group followed by chronic with the no-TMS group showing very little signal. Our results show that fMRI is a sensitive method to report SCI neuroplasticity and report differences in cortical responses between the groups at 10 weeks post-injury while the behavioral tests suggested that, by the same time all the rats reached a similar level of behavioral performance.

Our study highlights the importance of utilizing a combination of methods that can assess behavioral performance, motor behavior, and sensory function in monitoring individuals post-SCI. Using fMRI as an additional tool alongside behavioral and electrophysiological methods provides a sensitive assessment of cortical function as well as a method to detect minute compensatory changes in response to brain activation.

We suggest that post-SCI TMS therapy should be further tested for its efficacy and safety. Subsequently, this non-invasive strategy could be readily translated to the clinic as an adjuvant to traditional rehabilitation strategies. One of the limitations of our study is the use of general anesthesia during TMS treatments electrophysiology, and fMRI measurements in the animal model, which may not mimic the human condition. However, the insights gained from this and similar animal model studies are valuable in developing and evaluating new therapies. Moreover, our results suggest that early intervention is key for recovery and might play a role in medical strategies and trauma care interventions.
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